The role of adipocytokines in fetal growth

Annals of the New York Academy of Sciences

Volumn 1205, Issue , 2010, Pages 82-87

  Briana, Despina D ^a   Malamitsi Puchner, Ariadne ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

adipocytokines; adipose tissue; fetal growth; metabolic syndrome

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; FAT; LEPTIN; RESISTIN;

ADIPOCYTE; CONFERENCE PAPER; FETUS GROWTH; HORMONAL REGULATION; HORMONE ACTION; HUMAN; LIVER CELL; METABOLIC SYNDROME X; MUSCLE; PLACENTA; PRENATAL GROWTH; UTERUS; ANIMAL; DRUG EFFECTS; FEMALE; FETUS DEVELOPMENT; METABOLISM; PHYSIOLOGY; PREGNANCY;

ADIPOKINES; ANIMALS; FEMALE; FETAL DEVELOPMENT; HUMANS; PREGNANCY;

EID: 77957091736     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05650.x     Document Type: Conference Paper

References (40)

1. Gluckman, P.D., M.A. Hanson & C. Pinal. 2005. The developmental origins of adult disease. Matern. Child. Nutr. 1: 130-141.
2. Dorner,G.&A. Plagemann. 1994. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm. Metab. Res. 26: 213-221.
3. Meier, U. & A.M. Gressner. 2004. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 50: 1511-1525.
4. Kiess,W., S. Petzold, M. Topfer, et al. 2008. Adipocytes and adipose tissue. Best. Pract. Res. Clin. Endocrinol. Metab. 22: 135-153.
5. Wauters, M., R.V. Considine & L.F. Van Gaal. 2000. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur. J. Endocrinol. 143: 293-311.
6. Hoggard, N., P. Haggarty, L. Thomas, et al. 2001. Leptin expression in placental and fetal tissues: does leptin have a functional role? Biochem. Soc. Trans. 29: 57-62.
7. Forhead, A. & A.L. Fowden. 2009. The hungry fetus? Role of leptin as a nutritional signal before birth. J. Physiol. 587(Pt 6): 1145-1152.
8. Mounzih, K., J. Qui, A. Ewart-Toland, et al. 1998. Leptin is not necessary for gestation and parturition but regulates maternal nutrition via a leptin resistance state. Endocrinology 139: 5259-5262.
9. Lea, R.G.,D.Howe, L.T.Hannah, et al. 2000. Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol. Human. Reprod. 6: 763-769.
10. Schubring C., T. Siebler, J.Kratzsch, et al. 1999. Leptin serum concentrations in healthy neonates within the first week of life: relation to insulin and GH levels, skinfold thickness, BMI and weight. Clin. Endocrinol. 51: 199-204.
11. Devaskar, S.U., R.Anthony&W.Hay Jr. 2002. Ontogeny and insulin regulation of fetal ovine white adipose tissue leptin expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282: R431-R438.
12. Pighetti, M., G.A. Tommaselli, A. Delia, et al. 2003. Maternal serum and umbilical cord blood leptin concentrationswith fetal growth restriction.Obstet. Gynecol. 102: 535-543.
13. Vickers, M.H., P.D. Gluckman, A.H. Coveny, et al. 2005. Neonatal leptin treatment reverses developmental programming. Endocrinology 146: 4211-4216.
14. Vela-Huerta, M.M., E.U. San Vicente-Santoscoy, J.M. Guizar-Mendoza, et al. 2008. Leptin, insulin, and glucose serum levels in large-for-gestational-age infants of diabetic and non-diabetic mothers. J. Pediatr. Endocrinol.Metab. 21: 17-22.
15. Berg, A.H., T.P. Combs & P.E. Scherer. 2002. ACRP30/ adiponectin: an adipokine regulating glucose and lipid metabolism. Trends. Endocrinol. Metab. 13: 84-89.
16. Arita, Y., S. Kihara, N. Ouchi, et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257: 79-83.
17. Mazaki-Tovi, S., H. Kanety, C. Pariente, et al. 2005. Cord blood adiponectin in large-for-gestational-age newborns. Am. J. Obstet. Gynecol. 193: 1238-1242.
18. Kotani, Y., I. Yokota, S. Kitamura, et al. 2004. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin. Endocrinol. (Oxf). 61: 418-423.
19. Lindsay, R.S., J.D.Walker, P.J.Havel, et al. 2003. Adiponectin ispresent incordbloodbut isunrelatedtobirthweight. Diab. Care 26: 2244-2249.
20. Kajantie, E., T. Hytinantti, P. Hovi, et al. 2004. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. J. Clin. Endocrinol. Metab. 89: 4031-4036.
21. Pinar, H., S. Basu, K. Hotmire, et al. 2008. High molecular mass multimer complexes and vascular expression contribute to high adiponectin in the fetus. J. Clin. Endocrinol. Metab. 93: 2885-2890.
22. Corbetta, S., G. Bulfamante, D. Cortelazzi, et al. 2005. Adiponectin expression in human fetal tissues during midand late gestation. J. Clin. Endocrinol. Metab. 90: 2397-2402.
23. Caminos, J.E., R. Nogueira, R. Gallego, et al. 2005. Expression and regulation of adiponectin and receptor in human and rat placenta. J. Clin. Endocrinol. Metab. 90: 4276-4286.
24. Mantzoros, C., E. Petridou, D.M. Alexe, et al. 2004. Serum adiponectin concentrations in relation tomaternal and perinatal characteristics in newborns. Eur. J. Endocrinol. 151: 741-746.
25. Oshima, K., A. Nampei, M. Matsuda, et al. 2005. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 331: 520-526.
26. Yamauchi, T., J. Kamon, H. Waki, et al. 2001. The mechanisms by which both heterozygous peroxisome proliferatoractivated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 276: 41245-41254.
27. Kyriakakou, M., A. Malamitsi-Puchner, H. Militsi, et al. 2008. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates and their mothers. Eur. J. Endocrinol. 158: 343-348.
28. Ibanez, L., G. Sebastiani, A. Lopez-Bermejo, et al. 2008. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J. Clin. Endocrinol. Metab. 93: 2774-2778.
29. Kamoda, T., H. Saitoh, M. Saito, et al. 2004. Serum adiponectin concentrations innewborninfants in early postnatal life. Pediatr. Res. 56: 690-693.
30. Briana, D.D., M. Boutsikou, S. Baka, et al. 2008. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology 93: 153-157.
31. Malamitsi-Puchner A., D.D. Briana, D. Gourgiotis, et al. 2007. Blood visfatin concentrations in normal full-term pregnancies. Acta. Paediatr. 96: 526-529.
32. Briana, D.D., M. Boutsikou, D. Gourgiotis, et al. 2007. Role of visfatin, insulin-like growth factor-I and insulin in fetal growth. J. Perinat. Med. 35: 326-329.
33. Malamitsi-Puchner, A., D.D. Briana, M. Boutsikou, et al. 2007. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 119: E1314-E1318.
34. Steppan, C.M., S.T. Bailey, S. Bhat, et al. 2001. The hormone resistin links obesity to diabetes. Nature 409: 307-312.
35. Yura, S., N.N. Sagawa, H. Itoh, et al. 2003. Resistin is expressed in the human placenta. J. Clin. Endocrinol. Metab. 88: 1394-1397.
36. Cortelazzi, D., S. Corbetta, S. Ronzoni, et al. 2007.Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. 66: 447-453.
37. NG, P.C., C.H. Lee,C.W. Lam, et al. 2004. Plasma ghrelin and resistin concentrations are suppressed in infants of insulindependent diabetic mothers. J. Clin. Endocrinol. Metab. 89: 5563-5568.
38. Fukuhara, A., M. Matsuda, M. Nishizawa, et al. 2005. Visfatin: a protein secreted by visceral fat thatmimics the effects of insulin. Science 307: 426-430.
39. Sethi, J.K. & A. Vidal-Puig. 2005. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends.Mol. Med. 11: 344-347.
40. Ognjanovic, S. & G.D. Bryant-Greenwood. 2002. Pre- B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am. J. Obstet. Gynecol. 187: 1051-1058.